Na Li
Impact in
- Pharmacology top 0.05%
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 0.5%
- Phytochemicals and Antioxidant Activities
Papers in
-
- Natural product bioactivities and synthesis 45
- Metabolomics and Mass Spectrometry Studies 43
- Plant Science 125
- Co-authors
- Jian‐Lin Wu (75 shared papers)Ge Lin (20 shared papers)Yurong Lai (9 shared papers)Mingquan Guo (13 shared papers)Guilin Chen (8 shared papers)Nazzareno Ballatori (4 shared papers)Whitney V. Christian (3 shared papers)Hong Gao (5 shared papers)
- Journals
- Food Chemistry (23 papers)Journal of Natural Products (12 papers)Journal of Agricultural and Food Chemistry (11 papers)Frontiers in Pharmacology (11 papers)Scientific Reports (10 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Na Li
902 papers receiving 18.0k citations
Na Li's Hit Papers
Peers
Comparison fields: 5 of 209
- Pharmacology 2.1k
- Biochemistry 771
- Complementary and alternative medicine 859
- Analytical Chemistry 1.1k
- Molecular Biology 6.2k
Countries citing papers authored by Na Li
This map shows the geographic impact of Na Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Li more than expected).
Fields of papers citing papers by Na Li
This network shows the impact of papers produced by Na Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Li. The network helps show where Na Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Na Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 951 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 287 | |
| 2 | Skeletal muscle atrophy: From mechanisms to treatments Hit paper breakdown → | 2021 | 273 |
| 3 | 2010 | 219 | |
| 4 | 2019 | 214 | |
| 5 | 2018 | 203 | |
| 6 | YY1 lactylation in microglia promotes angiogenesis through transcription activation-mediated upregulation of FGF2 Hit paper breakdown → | 2023 | 192 |
| 7 | 2016 | 191 | |
| 8 | 2012 | 181 | |
| 9 | 2018 | 172 | |
| 10 | 2011 | 155 | |
| 11 | 2007 | 145 | |
| 12 | 2008 | 137 | |
| 13 | 2011 | 130 | |
| 14 | 2006 | 123 | |
| 15 | 2005 | 113 | |
| 16 | 2018 | 112 | |
| 17 | 2016 | 112 | |
| 18 | 1999 | 110 | |
| 19 | 2006 | 109 | |
| 20 | 2008 | 108 |
About Na Li
Na Li is a scholar working on Molecular Biology, Plant Science, Pharmacology, Food Science and Spectroscopy, having authored 951 papers that have together received 18.3k indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (45 papers), Metabolomics and Mass Spectrometry Studies (43 papers), Analytical Chemistry and Chromatography (42 papers), Phytochemicals and Antioxidant Activities (41 papers), Analytical chemistry methods development (40 papers), Mass Spectrometry Techniques and Applications (34 papers), Drug-Induced Hepatotoxicity and Protection (24 papers) and Pharmacological Effects of Natural Compounds (24 papers). The work is most often cited by research in Pharmacology (2.1k citations), Biochemistry (771 citations), Complementary and alternative medicine (859 citations), Analytical Chemistry (1.1k citations) and Molecular Biology (6.2k citations). Na Li has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Jian‐Lin Wu, Ge Lin, Yurong Lai, Mingquan Guo, Guilin Chen, Nazzareno Ballatori, Whitney V. Christian, Hong Gao, Xiqing Bian and Jianqing Ruan. Their work appears in journals such as Food Chemistry, Journal of Natural Products, Journal of Agricultural and Food Chemistry, Frontiers in Pharmacology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.